| Record ID | marc_loc_2016/BooksAll.2016.part01.utf8:39939807:1284 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part01.utf8:39939807:1284?format=raw |
LEADER: 01284cam a22003374a 4500
001 00057819
003 DLC
005 20020603162418.0
008 000629s2000 ne a b 101 0 eng c
010 $a 00057819
020 $a0444503161 (alk. paper)
035 $a(DNLM)100959153
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aR853.B54$bB564 2000
060 10 $aW3$bEX89 no.1205 2000
060 10 $aQH 438.4.B55$bB6145 2000
082 00 $a616.07/5$221
245 00 $aBiomarkers and surrogate endpoints :$bclinical research and applications : proceedings of the NIH-FDA conference held on 15-16 April 1999 in Bethesda, Maryland, USA /$cedited by Gregory J. Downing.
250 $a1st ed.
260 $aAmsterdam ;$aNew York :$bElsevier,$c2000.
300 $axxvii, 318 p. :$bill. ;$c25 cm.
440 0 $aInternational congress series ;$v1205
504 $aIncludes bibliographical references and index.
650 0 $aBiochemical markers$vCongresses.
650 0 $aMedicine$xResearch$xMethodology$vCongresses.
650 0 $aPharmacology$xResearch$xMethodology$vCongresses.
650 12 $aBiological Markers$vCongresses.
700 1 $aDowning, Gregory J.
710 2 $aNational Institutes of Health (U.S.)
710 1 $aUnited States.$bFood and Drug Administration.